Richard Bartram

Affiliations

  • Chief Financial Officer at Mbx Biosciences Inc. (MBX), 2024-09-13
  • Chief Financial Officer at Esperion Therapeutics Inc. (ESPR), 2022-03-16
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ESPR $43.62 1,500 Officer 11,092 2019-04-03 Filing
ESPR $42.71 6,500 Officer 12,592 2019-04-03 Filing